You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 126 No. 5, November 1970 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (47)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

The Red Blood Cell as a Model for the Study of Uremic Toxins

E. Kinsey M. Smith, MD; Louis G. Welt, MD

Arch Intern Med. 1970;126(5):827-830.


Abstract

Sodium transport abnormalities in uremia may be demonstrated in human erythrocytes by finding an increased intracellular sodium concentration. This is thought to be the result of an impaired sodium potassium pump associated with a defect in membrane adenosine triphosphatase (ATPase) which may serve as a link between the pump and its energy supply. The defect is reversed by effective treatment of uremia. Diminished activity of membrane ATPase can be induced in normal cells by incubation in plasma from patients with uremia whose erythrocytes have a high sodium concentration. Toxic substances known to accumulate in uremia do not inhibit the sodium pump or membrane ATPase in vitro. No single factor has yet been found which will induce the defect described, but the red blood cell is a useful model for further study of the metabolic defects induced by uremia.



Author Affiliations

Hamilton, Ontario, Canada; Chapel Hill, NC

From the departments of medicine, the University of North Carolina at Chapel Hill, and McMaster University, Hamilton, Ontario, Canada.


Footnotes

Received for publication June 22, 1970; accepted July 7.

Read before the session entitled "Hematologic Disorders" (Allen J. Erslev, MD, chairman) of the Symposium on Uremic Toxins sponsored by the National Institute of Arthritis and Metabolic Diseases, Monterey, Calif, March 18, 1970.

Reprint requests to Department of Medicine, McMaster University, Hamilton, Ontario, Canada (Dr. Smith).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Local Control of Vascular Resistance: as Related to Hypertension
Haddy
Arch Intern Med 1974;133:916-931.
ABSTRACT  

Erythrocyte Deformability in Uremic Hemodialyzed Patients
FORMAN et al.
ANN INTERN MED 1973;79:841-843.
ABSTRACT  

Pathological Alterations of Cation Movements in Red Blood Cells
Parker and Welt
Arch Intern Med 1972;129:320-332.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1970 American Medical Association. All Rights Reserved.